Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
7 May 2024 Job Information Organisation/Company Amsterdam UMC Research Field Medical sciences Researcher Profile First Stage Researcher (R1) Country Netherlands Application Deadline 21 May 2024 - 21
-
within a Research Infrastructure? No Offer Description The labs of Alan Gerber (Amsterdam UMC, Location VUmc) and Fred van Leeuwen (Netherlands Cancer Institute, NKI) are teaming up to crack the code
-
biomarkers with CRISPR-Cas13. This technology is ultra-sensative and may revolutionize ‘point of care ‘cancer diagnostics. You will work with state-of-the-art sequencing technologies to profile blood samples
-
following requirements: MSc in Neuroscience or Biomedical sciences; Good communicative and collaborative skills; Experience with data analysis/statistics; Critical attitude towards own and other's work; A
-
18 Apr 2024 Job Information Organisation/Company The Netherlands Cancer Institute Research Field Medical sciences Physics Other Researcher Profile Recognised Researcher (R2) First Stage Researcher
-
pivotal for optimal patient management. The current diagnostic laboratory procedure and algorithm for classification has limitations that can be overcome with fast Nanopore-sequence technology and deep
-
, activities and projects that will lead to accelaration of personalized therapies. A PhD in medicine, medical biology or a related field. Demonstrated experience in attracting external funding. A history of
-
. Requirements Specific Requirements We are looking for a PhD student with a master in Neuroscience, Cognitive neuroscience, Cognitive psychology, Biomedical engineering, Human-Computer Interaction, Signal